BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 31245299)

  • 1. Disease Tolerance in
    Melchor SJ; Ewald SE
    Front Cell Infect Microbiol; 2019; 9():185. PubMed ID: 31245299
    [No Abstract]   [Full Text] [Related]  

  • 2. Forward genetics screens using macrophages to identify Toxoplasma gondii genes important for resistance to IFN-γ-dependent cell autonomous immunity.
    Walwyn O; Skariah S; Lynch B; Kim N; Ueda Y; Vohora N; Choe J; Mordue DG
    J Vis Exp; 2015 Mar; (97):52556. PubMed ID: 25867017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxoplasma gondii effectors are master regulators of the inflammatory response.
    Melo MB; Jensen KD; Saeij JP
    Trends Parasitol; 2011 Nov; 27(11):487-95. PubMed ID: 21893432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune response and immunopathology during toxoplasmosis.
    Dupont CD; Christian DA; Hunter CA
    Semin Immunopathol; 2012 Nov; 34(6):793-813. PubMed ID: 22955326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-1R Regulates Disease Tolerance and Cachexia in
    Melchor SJ; Saunders CM; Sanders I; Hatter JA; Byrnes KA; Coutermarsh-Ott S; Ewald SE
    J Immunol; 2020 Jun; 204(12):3329-3338. PubMed ID: 32350081
    [No Abstract]   [Full Text] [Related]  

  • 6. From cells to signaling cascades: manipulation of innate immunity by Toxoplasma gondii.
    Denkers EY
    FEMS Immunol Med Microbiol; 2003 Dec; 39(3):193-203. PubMed ID: 14642303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Host persistence: exploitation of anti-inflammatory pathways by Toxoplasma gondii.
    Aliberti J
    Nat Rev Immunol; 2005 Feb; 5(2):162-70. PubMed ID: 15662369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subversion of innate and adaptive immune responses by Toxoplasma gondii.
    Lang C; Gross U; Lüder CG
    Parasitol Res; 2007 Jan; 100(2):191-203. PubMed ID: 17024357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Border maneuvers: deployment of mucosal immune defenses against Toxoplasma gondii.
    Cohen SB; Denkers EY
    Mucosal Immunol; 2014 Jul; 7(4):744-52. PubMed ID: 24717355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxoplasma gondii and subversion of the immune system.
    Buzoni-Gatel D; Werts C
    Trends Parasitol; 2006 Oct; 22(10):448-52. PubMed ID: 16904378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Communication between Toxoplasma gondii and its host: impact on parasite growth, development, immune evasion, and virulence.
    Blader IJ; Saeij JP
    APMIS; 2009 May; 117(5-6):458-76. PubMed ID: 19400868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of Toxoplasma gondii persistence and latency.
    Sullivan WJ; Jeffers V
    FEMS Microbiol Rev; 2012 May; 36(3):717-33. PubMed ID: 22091606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of Human Innate Immune Evasion by
    Lima TS; Lodoen MB
    Front Cell Infect Microbiol; 2019; 9():103. PubMed ID: 31041194
    [No Abstract]   [Full Text] [Related]  

  • 14. Dysregulation of macrophage signal transduction by Toxoplasma gondii: past progress and recent advances.
    Leng J; Butcher BA; Denkers EY
    Parasite Immunol; 2009 Dec; 31(12):717-28. PubMed ID: 19891610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aging with Toxoplasma gondii results in pathogen clearance, resolution of inflammation, and minimal consequences to learning and memory.
    McGovern KE; Cabral CM; Morrison HW; Koshy AA
    Sci Rep; 2020 May; 10(1):7979. PubMed ID: 32409672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of innate immunity by Toxoplasma gondii virulence effectors.
    Hunter CA; Sibley LD
    Nat Rev Microbiol; 2012 Nov; 10(11):766-78. PubMed ID: 23070557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of host immune responses to Toxoplasma gondii by microRNAs.
    Cai Y; Shen J
    Parasite Immunol; 2017 Feb; 39(2):. PubMed ID: 28170109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use and abuse of dendritic cells by Toxoplasma gondii.
    Sanecka A; Frickel EM
    Virulence; 2012 Nov; 3(7):678-89. PubMed ID: 23221473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic analysis of host resistance to intracellular pathogens: lessons from studies of Toxoplasma gondii infection.
    Yap GS; Shaw MH; Ling Y; Sher A
    Microbes Infect; 2006 Apr; 8(4):1174-8. PubMed ID: 16513380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Host cell invasion by the opportunistic pathogen Toxoplasma gondii.
    Carruthers VB
    Acta Trop; 2002 Feb; 81(2):111-22. PubMed ID: 11801218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.